Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chronic neurogenic pain

Purpose of the study. An analysis of the changes in components of the urokinase system in the brain of urokinase gene-knockout mice (uPA-/-) with B16/F10 melanoma growing alone and together with chronic neurogenic pain (CNP).Materials and methods. The study included male and female C57BL/6-PlautmI.I...

Full description

Saved in:
Bibliographic Details
Main Authors: E. M. Frantsiyants, V. A. Bandovkina, I. V. Kaplieva, N. D. Cheryarina, E. I. Surikova, I. V. Neskubina, Yu. A. Pogorelova, L. A. Nemashkalova
Format: Article
Language:Russian
Published: QUASAR, LLC 2022-03-01
Series:Исследования и практика в медицине
Subjects:
Online Access:https://www.rpmj.ru/rpmj/article/view/700
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568649713451008
author E. M. Frantsiyants
V. A. Bandovkina
I. V. Kaplieva
N. D. Cheryarina
E. I. Surikova
I. V. Neskubina
Yu. A. Pogorelova
L. A. Nemashkalova
author_facet E. M. Frantsiyants
V. A. Bandovkina
I. V. Kaplieva
N. D. Cheryarina
E. I. Surikova
I. V. Neskubina
Yu. A. Pogorelova
L. A. Nemashkalova
author_sort E. M. Frantsiyants
collection DOAJ
description Purpose of the study. An analysis of the changes in components of the urokinase system in the brain of urokinase gene-knockout mice (uPA-/-) with B16/F10 melanoma growing alone and together with chronic neurogenic pain (CNP).Materials and methods. The study included male and female C57BL/6-PlautmI.IBug-ThisPlau6FDhu/GFDhu mice (uPA-/-) (n = 48) and C57BL/6 mice (uPA+/+) (n = 80) with transplanted B16/F10 melanoma growing solitarily and together with CNP. Levels of the urokinase receptor (uPAR) and plasmin (PAP) and activity and levels of the PAI-I inhibitor were measured in the brain of animals by ELISA.Results. Levels of uPAR, PAI-I and PAP in the brain differed only in intact uPA-/- males, being on average 1.6 times higher (p < 0.05) than in uPA+/+ mice. Among animals with CNP, uPA-/- males showed increased PAI-I by 1.3 times (p < 0.05) and decreased PAP by 2.6 times (p < 0.05), while in uPA+/+ males, changes in PAI-I and PAP were opposite; in uPA-/- females, levels of all indicators increased by 1.6–2.1 times (p < 0.05), unlike uPA+/+ females. Among animals with melanoma only, changes in the levels of uPAR, PAI-I and PAP in the brain tissues in uPA-/- males differed from the group with CNP and from uPA+/+ males; in uPA+/+ females, levels of uPAR and PAP increased by 1.7 and 3.0 times (p < 0.05), and only PAP increased in uPA-/- females by 3.2 times (p < 0.05). Combination of CNP with melanoma in uPA-/- mice, regardless of their gender, down-regulated levels of uPAR and PAI-I on the average by 1.5 and 2.0 times, respectively (p < 0.05), and up-regulated PAP on the average by 2.2 times (p < 0.05) compared to the levels in animals with CNP; in uPA+/+ animals, similar decline of uPAR by 3.7 times (p < 0.05) was registered only in males, and an increase of PAI-I by 2.0 times (p < 0.05) was noted in all mice.Conclusion. Changes in the studied parameters in the brain tissue of urokinase gene-knockout animals in response to stress factors indicate the role of the brain urokinase system in the response to both CNP and melanoma growth, and the gender specificity of these changes may be another factor that conditions gender differences in the risk of occurrence and course of cutaneous melanoma.
format Article
id doaj-art-85aad20cd7b4480b8b7d07d31b5093c1
institution Kabale University
issn 2410-1893
language Russian
publishDate 2022-03-01
publisher QUASAR, LLC
record_format Article
series Исследования и практика в медицине
spelling doaj-art-85aad20cd7b4480b8b7d07d31b5093c12025-02-03T00:57:38ZrusQUASAR, LLCИсследования и практика в медицине2410-18932022-03-0191122210.17709/2410-1893-2022-9-1-1427Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chronic neurogenic painE. M. Frantsiyants0V. A. Bandovkina1I. V. Kaplieva2N. D. Cheryarina3E. I. Surikova4I. V. Neskubina5Yu. A. Pogorelova6L. A. Nemashkalova7National Medical Research Centre for OncologyNational Medical Research Centre for OncologyNational Medical Research Centre for OncologyNational Medical Research Centre for OncologyNational Medical Research Centre for OncologyNational Medical Research Centre for OncologyNational Medical Research Centre for OncologyNational Medical Research Centre for OncologyPurpose of the study. An analysis of the changes in components of the urokinase system in the brain of urokinase gene-knockout mice (uPA-/-) with B16/F10 melanoma growing alone and together with chronic neurogenic pain (CNP).Materials and methods. The study included male and female C57BL/6-PlautmI.IBug-ThisPlau6FDhu/GFDhu mice (uPA-/-) (n = 48) and C57BL/6 mice (uPA+/+) (n = 80) with transplanted B16/F10 melanoma growing solitarily and together with CNP. Levels of the urokinase receptor (uPAR) and plasmin (PAP) and activity and levels of the PAI-I inhibitor were measured in the brain of animals by ELISA.Results. Levels of uPAR, PAI-I and PAP in the brain differed only in intact uPA-/- males, being on average 1.6 times higher (p < 0.05) than in uPA+/+ mice. Among animals with CNP, uPA-/- males showed increased PAI-I by 1.3 times (p < 0.05) and decreased PAP by 2.6 times (p < 0.05), while in uPA+/+ males, changes in PAI-I and PAP were opposite; in uPA-/- females, levels of all indicators increased by 1.6–2.1 times (p < 0.05), unlike uPA+/+ females. Among animals with melanoma only, changes in the levels of uPAR, PAI-I and PAP in the brain tissues in uPA-/- males differed from the group with CNP and from uPA+/+ males; in uPA+/+ females, levels of uPAR and PAP increased by 1.7 and 3.0 times (p < 0.05), and only PAP increased in uPA-/- females by 3.2 times (p < 0.05). Combination of CNP with melanoma in uPA-/- mice, regardless of their gender, down-regulated levels of uPAR and PAI-I on the average by 1.5 and 2.0 times, respectively (p < 0.05), and up-regulated PAP on the average by 2.2 times (p < 0.05) compared to the levels in animals with CNP; in uPA+/+ animals, similar decline of uPAR by 3.7 times (p < 0.05) was registered only in males, and an increase of PAI-I by 2.0 times (p < 0.05) was noted in all mice.Conclusion. Changes in the studied parameters in the brain tissue of urokinase gene-knockout animals in response to stress factors indicate the role of the brain urokinase system in the response to both CNP and melanoma growth, and the gender specificity of these changes may be another factor that conditions gender differences in the risk of occurrence and course of cutaneous melanoma.https://www.rpmj.ru/rpmj/article/view/700urokinase gene knockoutb16/f10 melanomachronic neurogenic painurokinase receptorplasminplasminogen activator inhibitor
spellingShingle E. M. Frantsiyants
V. A. Bandovkina
I. V. Kaplieva
N. D. Cheryarina
E. I. Surikova
I. V. Neskubina
Yu. A. Pogorelova
L. A. Nemashkalova
Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chronic neurogenic pain
Исследования и практика в медицине
urokinase gene knockout
b16/f10 melanoma
chronic neurogenic pain
urokinase receptor
plasmin
plasminogen activator inhibitor
title Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chronic neurogenic pain
title_full Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chronic neurogenic pain
title_fullStr Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chronic neurogenic pain
title_full_unstemmed Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chronic neurogenic pain
title_short Changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene-knockout mice with B16/F10 melanoma growing together with chronic neurogenic pain
title_sort changes in levels of urokinase receptor and other components of fibrinolytic system in brain tissues in urokinase gene knockout mice with b16 f10 melanoma growing together with chronic neurogenic pain
topic urokinase gene knockout
b16/f10 melanoma
chronic neurogenic pain
urokinase receptor
plasmin
plasminogen activator inhibitor
url https://www.rpmj.ru/rpmj/article/view/700
work_keys_str_mv AT emfrantsiyants changesinlevelsofurokinasereceptorandothercomponentsoffibrinolyticsysteminbraintissuesinurokinasegeneknockoutmicewithb16f10melanomagrowingtogetherwithchronicneurogenicpain
AT vabandovkina changesinlevelsofurokinasereceptorandothercomponentsoffibrinolyticsysteminbraintissuesinurokinasegeneknockoutmicewithb16f10melanomagrowingtogetherwithchronicneurogenicpain
AT ivkaplieva changesinlevelsofurokinasereceptorandothercomponentsoffibrinolyticsysteminbraintissuesinurokinasegeneknockoutmicewithb16f10melanomagrowingtogetherwithchronicneurogenicpain
AT ndcheryarina changesinlevelsofurokinasereceptorandothercomponentsoffibrinolyticsysteminbraintissuesinurokinasegeneknockoutmicewithb16f10melanomagrowingtogetherwithchronicneurogenicpain
AT eisurikova changesinlevelsofurokinasereceptorandothercomponentsoffibrinolyticsysteminbraintissuesinurokinasegeneknockoutmicewithb16f10melanomagrowingtogetherwithchronicneurogenicpain
AT ivneskubina changesinlevelsofurokinasereceptorandothercomponentsoffibrinolyticsysteminbraintissuesinurokinasegeneknockoutmicewithb16f10melanomagrowingtogetherwithchronicneurogenicpain
AT yuapogorelova changesinlevelsofurokinasereceptorandothercomponentsoffibrinolyticsysteminbraintissuesinurokinasegeneknockoutmicewithb16f10melanomagrowingtogetherwithchronicneurogenicpain
AT lanemashkalova changesinlevelsofurokinasereceptorandothercomponentsoffibrinolyticsysteminbraintissuesinurokinasegeneknockoutmicewithb16f10melanomagrowingtogetherwithchronicneurogenicpain